Adalimumab

In the US, Adalimumab (adalimumab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Behcet's Disease, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Juvenile Idiopathic Arthritis, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Reiter's Syndrome, Rheumatoid Arthritis, Spondyloarthritis and Ulcerative Colitis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L04AA17,L04AB04

CAS registry number (Chemical Abstracts Service)

0331731-18-1

Chemical Formula

C6428-H9912-N1694-O1987-S46

Molecular Weight

144190

Therapeutic Categories

Immunosuppressant

Disease-modifying antirheumatic drug, DMARD

Anti-inflammatory agent

Monoclonal antibody

Tumor necrosis factor alpha (TNF-α) inhibitor

Chemical Name

Immunoglobulin G 1 (human monoclonal D2E7 heavy chain anti-human tumor necrosis factor), disulfide with human monoclonal D2E7κ-chain, dimer (WHO )

Foreign Names

  • Adalimumabum (Latin)
  • Adalimumab (German)
  • Adalimumab (French)
  • Adalimumab (Spanish)

Generic Names

Brand Names

  • Humira
    Abbott, Argentina; Abbott, Australia; Abbott, Belgium; Abbott, Bahrain; Abbott, Canada; Abbott, Switzerland; Abbott, Chile; Abbott, China; Abbott, Colombia; Abbott, Czech Republic; Abbott, Germany; Abbott, Denmark; Abbott, Ecuador; Abbott, Spain; Abbott, Finland; Abbott, France; Abbott, Greece; Abbott, Guatemala; Abbott, Hong Kong; Abbott, Honduras; Abbott, Croatia (Hrvatska); Abbott, Hungary; Abbott, Ireland; Abbott, Israel; Abbott, Italy; Abbott, South Korea; Abbott, Luxembourg; Abbott, Latvia; Abbott, Mexico; Abbott, Malaysia; Abbott, Netherlands; Abbott, Norway; Abbott, New Zealand; Abbott, Oman; Abbott, Panama; Abbott, Peru; Abbott, Poland; Abbott, Portugal; Abbott, Romania; Abbott, Serbia; Abbott, Russian Federation; Abbott, Sweden; Abbott, Singapore; Abbott, Slovenia; Abbott, Slovakia; Abbott, El Salvador; Abbott, Tunisia; Abbott, Turkey; Abbott, Taiwan; Abbott, United States; Abbott, South Africa; Abbott Japan, Japan; Abbott Laboratories, Austria; Abbott Laboratories S.A., Lithuania; AbbVie, United Kingdom
  • Trudexa
    Abbott, Latvia

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web5)